COVID-19 research briefs by Essential Evidence Plus (EE+)
As the COVID-19 pandemic continues to evolve, the CMA Joule team is working closely with Dr. Mark Ebell, Editor-in-Chief of Essential Evidence Plus (EE+) and the team at Wiley Publishing to share current research summaries with physicians.
*New in 2021* Selected COVID-19 research briefs are published as part of the regular POEMs schedule and will no longer be offered as a weekend supplement or posted below. The briefs are added daily to the American Academy of Family Physicians website: Coronavirus (COVID-19) Daily Research Briefs (aafp.org)
Subscribe to receive daily POEMS, refer to the POEMs archive (cma.ca login required) to comment on these summaries or collect CPD credits, or refer to the Essential Evidence Plus COVID-19 website.
How long do symptoms persist in patients who were hospitalized with COVID-19?
This study provides further evidence of the long-term persistence of COVID-19 symptoms. Approximately 30% of patients hospitalized with COVID-19 infection will have persistent symptoms for at least 60 days.
What effect has COVID-19 had on mortality by age, race, and ethnicity in the United States between January 2020 and October 2020?
Since January 2020, the United States has experienced almost 300,000 more deaths than would otherwise have been expected. The largest percentage increases were seen among 25- to 44-year-old persons and among Hispanic persons. Only two-thirds of the excess deaths been classified as COVID-19 deaths, suggesting an undercounting of COVID-19 as a cause of death.
How long do COVID-19 symptoms persist in people with mild to moderate infection?
Symptoms (weight loss, severe dyspnea or asthenia/fatigue, chest pain, palpitations, anosmia/ageusia, headache, cutaneous signs, arthralgia, myalgia, digestive disorders, fever, or sick leave) persist at 60 days for two-thirds of people with mild to moderate COVID infection.
*Disclaimer: POEMs stands for Patient-Oriented Evidence that Matters. POEMs is a publication of John Wiley and Sons, Inc. and distributed by CMA Joule as a CMA member service. All content is provided for information and education and not as a substitute for the advice of a physician. CMA Joule assumes no responsibility or liability arising from any error or omission or from the use of any information contained herein.
Clinical Relevance of Information Index
This is a relevance statistic called the Clinical Relevance of Information Index. It is derived from the answers provided by CMA members to the Impact Assessment Questionnaire.